Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Blood Outcomes Following Tocotrienol Supplementation - NUTRITION Phase I and Phase IIA

NCT01578629 is registered in ClinicalTrials.gov with Andrew Slivka as lead sponsor.

NCT NCT01578629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01578629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Blood Outcomes Following Tocotrienol Supplementation - NUTRITION Phase I and Phase IIA
Lead sponsor
Andrew Slivka
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2012
Completion date
December 31, 2018
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, transient ischemic attack (tia)